B16 as a mouse model for human melanoma.

Overwijk, W W; Restifo, N P

Overwijk, W W; Restifo, N P.

Affiliation

Overwijk WW; National Cancer Institute, NIH, Bethesda, Maryland, USA.

Curr Protoc Immunol ; Chapter 20: Unit 20.1, 2001 May.

Article in En | MEDLINE | ID: mdl-18432774

Subject(s)

Disease Models, Animal; Melanoma, Experimental; T-Lymphocytes, Cytotoxic/immunology; Animals; Cancer Vaccines/immunology; Cancer Vaccines/therapeutic use; Cytotoxicity, Immunologic; Granulocyte-Macrophage Colony-Stimulating Factor/immunology; Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use; Humans; Immunotherapy; Lung Neoplasms/secondary; Melanocytes/cytology; Melanocytes/enzymology; Melanocytes/immunology; Melanocytes/metabolism; Melanoma, Experimental/immunology; Melanoma, Experimental/pathology; Melanoma, Experimental/secondary; Melanoma, Experimental/therapy; Mice; Vaccines, Synthetic/genetics; Vaccines, Synthetic/immunology; Vaccines, Synthetic/virology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / T-Lymphocytes, Cytotoxic / Disease Models, Animal Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Protoc Immunol Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google